0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Effects of Antihypertensive Therapy on Serum Lipids

Bertram L. Kasiske, MD; Jennie Z. Ma, MS; Roberto S. N. Kalil, MD; and Thomas A. Louis, PhD
[+] Article and Author Information

From the University of Minnesota College of Medicine and Hennepin County Medical Center, Minneapolis, Minnesota. Requests for Reprints: Bertram L. Kasiske, MD, Department of Medicine, Hennepin County Medical Center, 701 Park Avenue, Minneapolis, MN 55415. Acknowledgment: The authors thank Ms. Jan Lovick and Ms. Anita Goth for their help in preparing the manuscript. A list of the studies included in the meta-analysis is available on request.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1995;122(2):133-141. doi:10.7326/0003-4819-122-2-199501150-00010
Text Size: A A A

Purpose: To compare and contrast the effects of antihypertensive agents on serum lipids and blood pressure in different patient populations.

Data Sources: A MEDLINE search and bibliographies from recent comprehensive reviews were used to identify trials that provided sufficient data to calculate the change in one or more serum lipid values measured before and after antihypertensive therapy.

Study Selection: 474 controlled and uncontrolled clinical trials investigated the effects of 85 antihypertensive agents on lipids and blood pressure in more than 65 000 patients.

Data Extraction: Data on triglyceride and total, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) cholesterol levels; blood pressure; patient characteristics; and study design.

Data Synthesis: Differences in the effects of agents, adjusted for differences in patient populations and study design, were examined using multiple linear regression analysis that was weighted by study quality and inverse variance. Diuretics caused relative increases in cholesterol levels (regression coefficient = 0.13 mmol/L; 95% CI, 0.09 to 0.18 mmol/L) that were greater with higher doses (additional effect of high dose, 0.12 mmol/L; CI, 0.04 to 0.20 mmol/L) and were worse in blacks than in nonblacks (additional effect in blacks, 0.13 mmol/L; CI, 0.01 to 0.26 mmol/L). β-blockers caused increases in triglyceride levels (0.35 mmol/L; CI, 0.31 to 0.39 mmol/L) that were substantially smaller for agents with intrinsic sympathomimetic activity (amelioration of β-blocker increase, −0.21 mmol/L; CI, −0.27 to −0.16 mmol/L). When combined with cardioselectivity, β-blockers with intrinsic sympathomimetic activity favorably affected lipids and reduced both total (−0.14 mmol/L; CI, −0.24 to −0.04 mmol/L) and LDL cholesterol levels (−0.17 mmol/L; CI, −0.28 to −0.07 mmol/L). α-Blockers beneficially affected total cholesterol (−0.23 mmol/L; CI, −0.28 to −0.18 mmol/L), LDL cholesterol (−0.20 mmol/L; CI, −0.25 to −0.15 mmol/L), triglycerides (−0.07 mmol/L; CI, −0.11 to −0.03 mmol/L), and, in younger persons, HDL cholesterol (0.02 mmol/L; 0.01 to 0.04 mmol/L). Converting enzyme inhibitors reduced triglycerides (−0.07 mmol/L; CI, −0.12 to −0.02 mmol/L), and, in patients with diabetes, total cholesterol (−0.22 mmol/L; CI, −0.34 to −0.10 mmol/L). Vasodilators reduced total (−0.22 mmol/l; CI, −0.30 to −0.10 mmol/L) and LDL cholesterol (−0.22 mmol/L; CI, −0.29 to −0.11 mmol/L) and increased HDL cholesterol (0.06 mmol/L; CI, 0.02 to 0.09 mmol/L).

Conclusion: With the exception of calcium antagonists, nearly all antihypertensive agents affect serum lipids. These effects differ among patient populations.

Figures

Grahic Jump Location
Figure 1.
Effect of patient characteristics on lipid changes caused by antihypertensive therapy.t

The effect of race on diuretic-associated changes in low density lipoprotein (LDL) cholesterol levels (mean ± SE) is shown in the left panel. Only groups for which race was reported in the study are included. Numbers in parentheses refer to the number of experimental groups with fewer than 50% blacks (15% ± 16%) or 50% or more blacks (86% ± 20%). The effect of sex on diuretic-associated changes in triglycerides is shown in the middle panel. Numbers in parentheses refer to the number of experimental groups with fewer than 50% men (27% ± 18%) or 50% or more men (82% ± 19%). The effect of diabetes on changes in cholesterol levels after treatment with an angiotensin-converting enzyme (ACE) inhibitor is shown in the right panel. Numbers in parentheses refer to the number of experimental groups with fewer than 50% patients with diabetes (1% ± 5%) or 50% or more patients with diabetes (100%). Significance was tested using an unweighted -test.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)